CSF Aβ38, Aβ40 and Aβ42 concentrations were measured using MSD Abeta Triplex (Meso Scale Discovery, Rockville, Maryland). CSF total tau (T-tau) and phosphorylated tau (P-tau) concentrations were measured using INNOTEST sandwich enzyme-linked immunosorbent assays (ELISAs, Fujirebio, Ghent, Belgium). CSF neurofilament light (NF-L) concentration was measured using the NF-Light ELISA (UmanDiagnostics, Umeå, Sweden). CSF YKL-40 (also called chitinase 3-like 1) concentration was measured using the Human Chitinase 3-like 1 Quantikine ELISA Kit (R&D Systems, Inc. Minneapolis, MN). CSF glial fibrillary acidic protein (GFAP) concentration was measured using an in-house ELISA [6 (link)]. All measurements were performed in one round of experiments with one batch of reagents and baseline and follow-up samples side by side on the assay plates by board-certified laboratory technicians who were blinded to clinical data.
Human chitinase 3 like 1 quantikine elisa kit
The Human Chitinase 3-like 1 Quantikine ELISA Kit is a quantitative sandwich enzyme-linked immunosorbent assay (ELISA) designed for the measurement of human Chitinase 3-like 1 levels in cell culture supernates, serum, and plasma.
Lab products found in correlation
11 protocols using human chitinase 3 like 1 quantikine elisa kit
CSF Biomarker Measurement Protocol
CSF Aβ38, Aβ40 and Aβ42 concentrations were measured using MSD Abeta Triplex (Meso Scale Discovery, Rockville, Maryland). CSF total tau (T-tau) and phosphorylated tau (P-tau) concentrations were measured using INNOTEST sandwich enzyme-linked immunosorbent assays (ELISAs, Fujirebio, Ghent, Belgium). CSF neurofilament light (NF-L) concentration was measured using the NF-Light ELISA (UmanDiagnostics, Umeå, Sweden). CSF YKL-40 (also called chitinase 3-like 1) concentration was measured using the Human Chitinase 3-like 1 Quantikine ELISA Kit (R&D Systems, Inc. Minneapolis, MN). CSF glial fibrillary acidic protein (GFAP) concentration was measured using an in-house ELISA [6 (link)]. All measurements were performed in one round of experiments with one batch of reagents and baseline and follow-up samples side by side on the assay plates by board-certified laboratory technicians who were blinded to clinical data.
Quantification of Neuroinflammatory Biomarkers
Profiling Soluble Biomarkers in MPS
Cytokine profiles in cell culture medium samples were also analysed by Luminex array for determination of 38 analytes in total, consisting of cytokines, chemokines, and growth factors using the MILLIPLEX MAP Human Cytokine/Chemokine Magnetic Bead Panel - Premixed 38 Plex (Merck Millipore, USA). In total 15 of the analytes were observed to have no detectable expression or had no significant differences between any of the culture conditions so were excluded from the analysis.
Serum Biomarker Measurement Protocol
Quantifying CSF YKL-40 by ELISA
On a capture-antibody precoated 96-well microtiter plate, 50 μL of CSF sample, calibrator, or controls were added followed by addition of 200 μL of conjugate and incubation at room temperature for 2 hours. Finally, each well was washed in the provided washing buffer, followed by addition of 200 μL substrate solution, and subsequently stopped with 50 μL of the provided stop solution. Quantification was carried out at 540/570 nm in a microplate reader.
All biochemical measurements were performed by board-certified laboratory technicians who were blinded to clinical information. The measurements were performed in one round of experiments using one batch of reagents. Intra-assay coefficients of variation were below 10%.
Cerebrospinal Fluid Biomarker Analysis
CSF Biomarker Analysis Protocol
CSF Aβ42, tau, and P‐tau were analyzed using AlzBio3 (Fujirebio, Ghent, Belgium), NFL was analysed using the NF‐light assay (UmanDiagnostics, Umeå, Sweden), YKL‐40 was analyzed using the Human Chitinase 3‐like 1 Quantikine ELISA Kit (R&D, Minneapolis, Minnesota), α‐syn was analyzed using the Covance assay (Covance, Dedham, Massachusetts), and haemoglobin was analyzed with an assay provided by Bethyl Lab, Inc. (Montgomery, Texas). For α‐syn, only samples with haemoglobin <200 ng/ml were used; consequently, 4 samples from PD patients (all PD with long disease duration) and 1 sample from the controls were excluded, all baseline samples.
For P‐tau there were 8 missing in the control group and 16 missing in the PD group. Baseline and follow‐up CSF samples were always analyzed in the same batch. All analyses were performed using 1 batch of reagents by board‐certified laboratory technicians who were blinded to clinical data. Intra‐assay coefficients of variation were below 10%.
Quantifying CSF Biomarkers Using ELISA
Samples were diluted where necessary to achieve a concentration within the linear range of standard curve measurements. Median intraassay and interassay coefficients of variation were below 10% for all assays: CHIT1 intraassay median 6.9% (IQR 2.9%–15.6%), interassay 4.0% (2.4%–5.2%), lower limit of detection (LLOD) 48.3 pg/mL; CHI3L1 5.8% (2.4%–12.09%), 2.6% (1.4%–11.9%), LLOD 3.55 pg/mL; CHI3L2 3.5% (1.2–7.3), 3.0% (0.7%–6.2%), LLOD 35.1 pg/mL; and CHIT1 activity 6.3% (1.7%–13.9%), 1.58% (0.8%–2.5%), LLOD 12.0 nmol/h/mL. Samples for which the analyte value was unmeasurably low were imputed with the LLOD.
Biomarkers of Neurodegenerative Diseases
Quantitative Chitinase 3-like 1 Assay
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!